| MTH1 in complex with TH013071 | | homo-2-mer | 1-156 | 100 | 2×KYI; 1×ACT; 6×SO4; |
|
| Crystal structure of NUDT1 (MTH1) with S-crizotinib | | homo-2-mer | 3-156 | 100 | 2×VHS; 2×CL; 10×SO4; |
|
| Crystal structure of NUDT1 (MTH1) with R-crizotinib | | homo-2-mer | 3-156 | 100 | 2×CL; 2×VGH; 10×SO4; |
|
| Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 2-oxo-dATP | | monomer | 1-156 | 98.08 | 1×6U4; 2×NA; |
|
| Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 8-oxo-dGTP determined using … | | monomer | 1-156 | 98.08 | 1×8DG; 3×NA; 2×GOL; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 8.6 | | monomer | 1-156 | 99.35 | 1×6U4; 4×NA; |
|
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP at pH 9.7 | | monomer | 1-156 | 98.72 | 1×6U4; 2×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 7.7 | | monomer | 1-156 | 99.36 | 1×8DG; 2×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 8.0 | | monomer | 1-156 | 99.36 | 1×6U4; 3×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 9.1 | | monomer | 1-156 | 99.35 | 1×6U4; 2×NA; 1×GOL; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 9.7 | | monomer | 1-156 | 99.35 | 2×NA; 1×GOL; |
|
| Crystal structure of human MTH1(G2K/D120A mutant) in complex with 2-oxo-dATP under high concentrati… | | monomer | 1-156 | 98.72 | 1×6U4; 2×NA; |
|
| Crystal structure of human MTH1(G2K/D120A mutant) in complex with 8-oxo-dGTP | | monomer | 1-156 | 98.72 | 1×GOL; 1×NA; |
|
| Crystal structure of human MTH1(G2K/D120A mutant) in complex with 2-oxo-dATP | | monomer | 1-156 | 98.72 | 1×NA; |
|
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP at pH 7.7 | | monomer | 1-156 | 98.72 | 1×6U4; 2×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP | | monomer | 1-156 | 99.36 | 1×6U4; 2×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 7.7 | | monomer | 1-156 | 99.35 | 1×6U4; 3×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP | | monomer | 1-156 | 99.36 | 1×8DG; 2×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dAMP and Mn2+ | | monomer | 1-156 | 99.36 | 1×IGU; 3×MN; |
|
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP | | monomer | 1-156 | 98.72 | 1×6U4; 2×NA; |
|
| Crystal structure of hMTH1 N33A in complex with LW14 in the presence of acetate | | monomer | 1-156 | 99.36 | 1×BU8; 1×SO4; 1×ACT; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 8.6 | | monomer | 1-156 | 99.35 | 1×8DG; 4×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 9.1 | | monomer | 1-156 | 99.35 | 3×NA; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGMP and Mn2+ | | monomer | 1-156 | 99.36 | 1×8OG; 3×MN; |
|
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 8-oxo-dGTP at pH 6.5 | | monomer | 1-156 | 98.72 | 1×8DG; |
|
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 8.0 | | monomer | 1-156 | 99.36 | 1×8DG; 3×NA; |
|
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 8-oxo-dGTP at pH 7.0 | | monomer | 1-156 | 98.72 | 1×8DG; 1×NA; |
|
| Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the absence of acetate | | monomer | 1-156 | 99.36 | 2×F3E; 4×SO4; |
|
| Complex between MTH1 and compound 29 (a 4-amino-2,7-diazaindole derivative) | | monomer | 1-156 | 100 | 1×C9B; 5×SO4; |
|
| Crystal structure of hMTH1 N33G in complex with LW14 in the absence of acetate | | monomer | 1-156 | 99.36 | 1×BU8; 4×SO4; |
|
| Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the presence of acetate | | monomer | 1-156 | 99.36 | 2×F3E; 1×ACT; 3×SO4; |
|
| Crystal structure of hMTH1 N33G in the presence of acetate | | monomer | 1-156 | 99.36 | 2×SO4; |
|
| Crystal structure of human MTH1 in complex with O6-methyl-dGMP | | monomer | 1-156 | 100 | 4×SO4; 1×ACT; 1×6OG; |
|
| Complex between MTH1 and compound 16 (a 4-amino-7-azaindole derivative) | | monomer | 1-156 | 100 | 1×C8Z; 5×SO4; 2×GOL; |
|
| Complex between MTH1 and compound 1 (a 7-azaindole-4-ester derivative) | | monomer | 1-156 | 100 | 1×C9E; 5×SO4; 2×ACT; |
|
| Solution structure of the hMTH1, a nucleotide pool sanitization enzyme | | monomer | 1-156 | 100 | |
|
| Crystal structure of hMTH1 F27A in complex with LW14 in the presence of acetate | | monomer | 2-156 | 99.36 | 1×BU8; 1×SO4; 1×ACT; |
|
| Crystal structure of MTH1 in complex with compound 32 | | monomer | 2-156 | 100 | 1×ZRV; 2×SO4; |
|
| Potent and selective inhibitors of MTH1 probe its role in cancer cell survival | | monomer | 2-156 | 100 | 1×RX8; |
|
| Crystal structure of hMTH1 D120N in complex with TH scaffold 1 in the absence of acetate | | monomer | 2-156 | 99.36 | 1×F3E; 4×SO4; |
|
| MTH1 in complex with fragment 4 | | monomer | 2-156 | 100 | 1×AX7; 1×SO4; |
|
| Potent and selective inhibitors of MTH1 probe its role in cancer cell survival | | monomer | 2-156 | 100 | 1×RJE; |
|
| Crystal structure of MTH1 in complex with compound 31 | | monomer | 3-156 | 100 | 1×ZRP; 2×SO4; |
|
| MTH1 in complex with compound 15 | | monomer | 3-156 | 100.0 | 1×RGJ; |
|
| Crystal structure of hMTH1 F27A in complex with LW14 in the absence of acetate | | monomer | 3-156 | 99.35 | 1×BU8; 2×SO4; |
|
| MTH1 substrate recognition: Complex with a methylaminopurinone | | monomer | 3-156 | 100 | 1×UAN; 1×SO4; |
|
| Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the absence of acetate | | monomer | 3-156 | 99.35 | 4×SO4; 1×F3E; |
|
| MTH1 in complex with compound 24 | | monomer | 3-156 | 100 | 1×9CQ; |
|
| MTH1 in complex with TH013350 | | monomer | 3-156 | 100 | 2×KOX; 1×SO4; |
|
| MTH1 in complex with fragment 8 | | monomer | 3-156 | 100 | 1×BSW; 2×SO4; |
|
| Crystal structure of hMTH1 N33A in complex with TH scaffold 1 in the absence of acetate | | monomer | 3-156 | 99.35 | 1×F3E; 4×SO4; |
|
| Crystal structure of hMTH1 in complex with TH scaffold 1 in the presence of acetate | | monomer | 3-156 | 100 | 1×F3E; 1×SO4; |
|
| MTH1 in complex with compound 4 | | monomer | 3-156 | 100 | 1×8JF; |
|
| Crystal structure of hMTH1 N33A in the presence of acetate | | monomer | 3-156 | 99.35 | 3×SO4; |
|
| MTH1 in complex with fragment 11 | | monomer | 3-156 | 100 | 1×BS8; 1×SO4; |
|
| Crystal structure of human MTH1 in complex with inhibitor 7-(furan-2-yl)-5-methyl-1,3-benzoxazol-2-… | | monomer | 3-156 | 100 | 1×8WZ; 2×SO4; |
|
| The Crystal Structure of human MTH1 from Biortus | | monomer | 3-156 | 100 | 1×PG4; 1×PEG; |
|
| MTH1 substrate recognition: Complex with 8-oxo-dGTP. | | monomer | 3-156 | 100 | 1×H6Y; 1×ACT; |
|
| Crystal structure of hMTH1 D120N in the presence of acetate | | monomer | 3-156 | 99.35 | 1×DMS; |
|
| MTH1 in complex with TH013074 | | monomer | 3-156 | 100 | 1×KYR; 1×SO4; |
|
| Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the presence of acetate | | monomer | 3-156 | 99.35 | 1×F3E; |
|
| Crystal structure of hMTH1 N33A in complex with LW14 in the absence of acetate | | monomer | 3-156 | 99.35 | 1×BU8; 2×SO4; |
|
| Structure of human MTH1 in complex with TH287 | | monomer | 3-156 | 100 | 1×2GD; 4×SO4; |
|
| MTH1 substrate recognition: Complex with 8-oxo-dGTP. | | monomer | 3-156 | 100 | 1×8DG; |
|
| MTH1 substrate recognition: Complex with a methylbenzimidazolyl acetamide. | | monomer | 3-156 | 100 | 1×ACT; 1×N91; 3×DMS; |
|
| MTH1 substrate recognition: Complex with a methylaminopyrimidinedione. | | monomer | 3-156 | 100 | 1×ACT; 1×S76; 2×DMS; |
|
| MTH1 substrate recognition: Complex with a aminomethylpyrimidinyl oxypropanol. | | monomer | 3-156 | 100 | 1×6Q3; 1×ACT; 1×DMS; |
|
| Crystal structure of hMTH1 D120N in complex with LW14 in the presence of acetate | | monomer | 3-156 | 99.35 | 1×BU8; |
|
| BAY-707 in complex with MTH1 | | monomer | 3-156 | 100 | 1×8XT; 6×SO4; 1×GOL; |
|
| Crystal structure of human apo MTH1 | | monomer | 3-156 | 100 | |
|
| MTH1 in complex with fragment 9 | | monomer | 3-156 | 100 | 1×BU5; 1×SO4; |
|
| Crystal structure of human MTH1 in complex with 8-oxo-dGMP | | monomer | 3-156 | 100 | 1×8OG; 2×SO4; |
|
| MTH1 in complex with compound 15 | | monomer | 3-156 | 100 | 1×DMS; 1×58T; |
|
| Crystal Structure of Human 8-oxo-dGTPase (MTH1) | | monomer | 3-156 | 100 | 3×SO4; 1×IMD; 2×GOL; |
|
| MTH1 in complex with compound 5 | | monomer | 3-156 | 100 | 1×S3O; |
|
| Crystal structure of human MTH1 in complex with compound MI1030 | | monomer | 3-156 | 100 | 1×CJR; |
|
| MTH1 in complex with fragment 6 | | monomer | 3-156 | 100 | 1×BU8; |
|
| Crystal structure of human MTH1 in complex with compound MI0639 | | monomer | 3-156 | 100 | 1×95F; |
|
| Crystal structure of human MTH1 in complex with inhibitor 6-[(2-phenylethyl)sulfanyl]-7H-purin-2-am… | | monomer | 3-156 | 100 | 1×8WW; 6×SO4; 1×ACT; |
|
| MTH1 in complex with TH012532 | | monomer | 3-156 | 100 | 1×KLO; 1×GOL; 6×SO4; |
|
| Crystal structure of MTH1 in complex with alpha-mangostin (cocktail No. 9) | | monomer | 3-156 | 100 | 2×ZN; 1×MKS; 1×SO4; |
|
| Complex between MTH1 and compound 7 (a 7-azaindole-2-amide derivative) | | monomer | 3-156 | 100 | 1×C9Q; 3×SO4; |
|
| Crystal structure of human MTH1 in complex with compound MI1014 | | monomer | 3-156 | 100 | 1×CG0; |
|
| Crystal structure of human MTH1 | | monomer | 3-156 | 100 | 1×ACT; 3×SO4; |
|
| Crystal structure of MTH1 in complex with 3-isomangostin | | monomer | 3-156 | 100 | 1×MKU; 3×ZN; 1×SO4; |
|
| Crystal structure of human MTH1 in complex with compound MI1022 | | monomer | 3-156 | 100 | 1×CJ6; |
|
| MTH1 in complex with compound 32 | | monomer | 3-156 | 100 | 1×GN6; |
|
| Crystal structure of hMTH1 F27A in the presence of acetate | | monomer | 3-156 | 99.35 | |
|
| Crystal structure of MTH1 in apo form (cocktail No. 1) | | monomer | 3-156 | 100 | 3×ZN; 1×SO4; |
|
| MTH1 in complex with fragment 1 | | monomer | 3-156 | 100 | 1×EV2; 1×ACT; 1×SO4; |
|
| Crystal structure of human MTH1 in complex with compound MI0320 | | monomer | 3-156 | 100 | 1×95L; |
|
| Crystal structure of human MTH1 in complex with compound MI1016 | | monomer | 3-156 | 100 | 1×CGX; |
|
| Crystal structure of human MTH1 in complex with compound MI1029 | | monomer | 3-156 | 100 | 1×CJL; |
|
| Crystal structure of MTH1 in complex with 18-Crown-6 | | monomer | 3-156 | 100 | 3×ZN; 1×SO4; 2×O4B; 1×VGH; |
|
| Crystal structure of human MTH1 in complex with compound MI1012 | | monomer | 3-156 | 100 | 1×CEU; |
|
| Crystal structure of human MTH1 in complex with compound MI1020 | | monomer | 3-156 | 100 | 1×CJ0; |
|
| MTH1 in complex with TH001969 | | monomer | 3-156 | 100 | 1×L3N; 3×SO4; |
|
| Crystal structure of human MTH1 in complex with compound MI1025 | | monomer | 3-156 | 100 | 1×CJF; |
|
| Crystal structure of human MTH1 in complex with fragment inhibitor 8-(methylsulfanyl)-7H-purin-6-am… | | monomer | 3-156 | 100 | 1×8WT; 4×SO4; |
|
| Crystal structure of human MTH1 in complex with compound MI1024 | | monomer | 3-156 | 100 | 1×CJ9; |
|
| Crystal structure of human MTH1 in complex with compound MI0861 | | monomer | 3-156 | 100 | 1×95R; 1×SO4; |
|
| Crystal structure of human MTH1 in complex with compound MI1026 | | monomer | 3-156 | 100 | 1×CJU; |
|
| Crystal structure of human MTH1 in complex with compound MI1006 | | monomer | 3-156 | 100 | 1×C9L; |
|
| Crystal structure of human MTH1 in complex with N6-methyl-dAMP | | monomer | 3-156 | 100 | 3×SO4; 1×6MA; |
|
| MTH1 in complex with Ruthenium-based inhibitor | | monomer | 3-156 | 100 | 3×SO4; 1×RUX; |
|
| Crystal structure of hMTH1 N33G in complex with LW14 in the presence of acetate | | monomer | 1-153 | 99.35 | 1×BU8; 2×SO4; 1×ACT; |
|
| Structure of human MTH1 in complex with TH588 | | monomer | 3-155 | 100 | 1×2GE; 7×SO4; |
|